BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Sep 27, 2025; 17(9): 107977
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.107977
Table 1 Comparison of baseline characteristics in training and test cohorts, n (%)
Characteristic
All (n = 579)
Training cohort (n = 405)
Testing cohort (n = 174)
P value
Female207 (35.7)139 (34.3)68 (39.1)0.27
Age (≥ 65 years)190 (32.8)132 (32.6)58 (333.3)0.86
BMI, kg/m223.1 (3.0)23.0 (3.0)23.1 (3.0)0.80
Smoking141 (24.4)102 (25.2)39 (22.4)0.48
Alcohol use86 (14.9)58 (14.3)28 (16.1)0.49
Hypertension154 (26.6)105 (25.9)49 (28.1)0.58
Diabetes72 (12.4)49 (12.1)23 (13.2)0.71
Previous abdominal surgery89 (15.3)62 (15.3)27 (15.5)0.95
Tumorous obstruction27 (4.7)19 (4.7)8 (4.6)0.96
Neoadjuvant therapy89 (15.3)65 (16.1)24 (13.8)0.49
Electrolyte disorders89 (15.4)62 (15.3)27 (15.5)0.95
Albumin, g/L40.1 (4.0)40.1 (3.9)40.1 (4.1)0.97
CEA (> 5 ng/mL)143 (24.7)95 (23.5)48 (27.6)0.29
Tumor size, cm3.4 (1.3)3.4 (1.2)3.5 (1.3)0.76
Tumor distance, cm6.4 (2.4)6.4 (2.3)6.5 (2.5)0.57
Laparoscopic surgery563 (97.2)394 (97.2)169 (97.1)0.96
Operative time, minutes219.1 (57.1)220.4 (57.4)215.9 (56.4)0.39
Intraoperative bleeding, ml75.8 (122.6)79.1 (122.5)68.3 (123.1)0.34
ASA0.97
    I, II507 (91.0)354 (91.8)153 (91.5)
    III, IV72 (9.0)51 (8.1)21 (8.5)
Clinical stages0.38
    1158 (27.2)113 (27.9)45 (25.9)
    2189 (32.6)1255 (30.8)64 (36.8)
    3232 (40.1)167 (41.2)65 (37.3)
PSF31 (5.3)21 (5.1)10 (5.7)0.42
Table 2 Performance metrics for five different models in the training cohort
Model
AUC (95%CI)
Accuracy
Sensitivity
Specificity
PPV
NPV
RF0.909 (0.844-0.974)0.8910.8570.8930.3050.991
LR0.876 (0.800-0.953)0.7850.8090.7830.1700.986
KNN0.884 (0.825-0.954) 0.9200.7140.9320.3650.983
XGBoost0.879 (0.812-0.945) 0.8290.7610.8330.2000.984
SVM0.870 (0.786-0.955) 0.859 0.8570.8590.2500.990